{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pitavastatin+4mg", "query": { "intervention": "Pitavastatin 4mg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 6, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-12T15:58:28.049Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01178853", "title": "Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Warfarin", "type": "DRUG" }, { "name": "Warfarin 5mg + Rosuvastatin 40 mg once daily (QD)", "type": "DRUG" }, { "name": "Warfarin 5 mg + Pitavastatin 4mg once daily (QD)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kowa Research Institute, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 48, "start_date": "2010-07", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-10-08", "last_synced_at": "2026-09-12T15:58:28.049Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01178853" }, { "nct_id": "NCT02634034", "title": "A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hyperlipidemia" ], "interventions": [ { "name": "A: NK-104-CR 8 mg", "type": "DRUG" }, { "name": "B: Pitavastatin IR 4 mg", "type": "DRUG" }, { "name": "C: Pitavastatin IR 8 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kowa Research Institute, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 18, "start_date": "2015-12", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2016-01-11", "last_synced_at": "2026-09-12T15:58:28.049Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02634034" }, { "nct_id": "NCT01660191", "title": "A Study Comparing CoQ10 Levels While Taking 3 Different Statins", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "Pitavastin 4mg", "type": "DRUG" }, { "name": "Atorvastatin 20mg", "type": "DRUG" }, { "name": "Rosuvastatin 5mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 134, "start_date": "2011-12", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-09-12T15:58:28.049Z", "location_count": 1, "location_summary": "Kansas City, Kansas", "locations": [ { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01660191" }, { "nct_id": "NCT02290106", "title": "Effects of Pitavastatin on Insulin Sensitivity and Liver Fat", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Fatty Liver, Nonalcoholic" ], "interventions": [ { "name": "pitavastatin", "type": "DRUG" }, { "name": "PLACEBO", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "40 Years to 65 Years · Male only" }, "enrollment_count": 50, "start_date": "2015-03-02", "completion_date": "2018-04-30", "has_results": true, "last_update_posted_date": "2019-07-02", "last_synced_at": "2026-09-12T15:58:28.049Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02290106" }, { "nct_id": "NCT01043094", "title": "Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Severe Renal Impairment" ], "interventions": [ { "name": "Pitavastatin 4mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kowa Research Institute, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2009-12", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2012-08-13", "last_synced_at": "2026-09-12T15:58:28.049Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01043094" }, { "nct_id": "NCT01422369", "title": "Drug-Drug Interaction of Darunavir/Ritonavir on Pitavastatin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Pitavastatin (NK-104)", "type": "DRUG" }, { "name": "Darunavir/Ritonavir (Prezista)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kowa Research Institute, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 28, "start_date": "2011-04", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2012-07-13", "last_synced_at": "2026-09-12T15:58:28.049Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01422369" } ] }